Recent Quarter Total Invested
$1.36 B
Recent Quarter Institutional Ownership Percentage
118.38%
Total Invested of Last Quarter
$718.57 M
Ownership Percentage of Last Quarter
89.06%
Nurix Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK INC. | 08/13/2024 | 6.82 M | $142.33 M | 48.90% | 12.42% |
| REDMILE GROUP, LLC | 08/14/2024 | 4.42 M | $92.32 M | -1.33% | 8.06% |
| DEEP TRACK CAPITAL, LP | 08/14/2024 | 3.99 M | $83.30 M | 33.15% | 7.27% |
| BAKER BROS. ADVISORS LP | 08/14/2024 | 3.88 M | $81.02 M | 0.00% | 7.07% |
| VANGUARD GROUP INC | 08/13/2024 | 3.63 M | $75.65 M | 40.27% | 6.60% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 3.20 M | $66.82 M | 1,273.39% | 5.83% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 2.84 M | $59.17 M | 29.09% | 5.16% |
| STATE STREET CORP | 08/14/2024 | 2.71 M | $56.53 M | -0.76% | 4.93% |
| ARK INVESTMENT MANAGEMENT LLC | 07/26/2024 | 2.32 M | $48.49 M | -11.84% | 4.23% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2024 | 2.19 M | $45.69 M | 100.00% | 3.99% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 2.06 M | $42.91 M | 84.39% | 3.74% |
| MORGAN STANLEY | 08/14/2024 | 1.99 M | $41.53 M | -21.38% | 3.62% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.32 M | $27.59 M | 20.12% | 2.41% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 08/15/2024 | 1.28 M | $26.78 M | 100.00% | 2.34% |
| PICTET ASSET MANAGEMENT HOLDING SA | 08/13/2024 | 1.17 M | $24.49 M | 61.43% | 2.14% |
| CANDRIAM S.C.A. | 08/05/2024 | 1.16 M | $24.30 M | 30.50% | 2.12% |
| DEUTSCHE BANK AG\ | 08/14/2024 | 1.05 M | $21.88 M | -30.08% | 1.91% |
| CITADEL ADVISORS LLC | 08/14/2024 | 1.04 M | $21.72 M | 384.67% | 1.90% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 981,167 | $20.48 M | 134.27% | 1.79% |
| AFFINITY ASSET ADVISORS, LLC | 08/14/2024 | 912,000 | $19.03 M | 12.56% | 1.66% |
| WASATCH ADVISORS LP | 08/14/2024 | 858,067 | $17.91 M | -30.62% | 1.56% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 650,000 | $13.57 M | 100.00% | 1.18% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 623,404 | $13.01 M | -2.93% | 1.14% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 603,133 | $12.59 M | -37.59% | 1.10% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 599,623 | $12.51 M | 60.22% | 1.09% |
| SAMLYN CAPITAL, LLC | 08/14/2024 | 583,490 | $12.18 M | 100.00% | 1.06% |
| NORGES BANK | 08/14/2024 | 507,536 | $10.59 M | 100.00% | 0.92% |
| VESTAL POINT CAPITAL, LP | 08/14/2024 | 500,000 | $10.44 M | 100.00% | 0.91% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2024 | 474,679 | $9.91 M | 89.87% | 0.86% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 464,507 | $9.69 M | -5.72% | 0.85% |
| IKARIAN CAPITAL, LLC | 08/14/2024 | 440,500 | $9.19 M | 46.83% | 0.80% |
| NORTHERN TRUST CORP | 08/14/2024 | 438,089 | $9.14 M | 8.44% | 0.80% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 432,289 | $9.02 M | 64.89% | 0.79% |
| OPALEYE MANAGEMENT INC. | 08/14/2024 | 418,928 | $8.74 M | 56.78% | 0.76% |
| INVESCO LTD. | 08/13/2024 | 365,298 | $7.62 M | 16.74% | 0.67% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 08/14/2024 | 334,972 | $6.99 M | 100.00% | 0.61% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 324,000 | $6.76 M | 80.70% | 0.59% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 08/13/2024 | 320,552 | $6.69 M | 93.57% | 0.58% |
| ARROWMARK COLORADO HOLDINGS LLC | 08/14/2024 | 314,762 | $6.57 M | 0.00% | 0.57% |
| BESSEMER GROUP INC | 08/13/2024 | 306,003 | $6.39 M | -14.35% | 0.56% |
| WOODLINE PARTNERS LP | 08/14/2024 | 301,887 | $6.30 M | 100.00% | 0.55% |
| PRIMECAP MANAGEMENT CO/CA/ | 08/09/2024 | 290,000 | $6.05 M | 3.94% | 0.53% |
| WESTHILL FINANCIAL ADVISORS, INC. | 07/19/2024 | 283,333 | $5.91 M | 0.00% | 0.52% |
| TREXQUANT INVESTMENT LP | 08/13/2024 | 238,582 | $4.98 M | 12.07% | 0.43% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2024 | 224,908 | $4.69 M | -48.23% | 0.41% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 221,327 | $4.62 M | 127.76% | 0.40% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 209,136 | $4.36 M | 31.35% | 0.38% |
| STEMPOINT CAPITAL LP | 08/13/2024 | 203,273 | $4.24 M | 100.00% | 0.37% |
| JANE STREET GROUP, LLC | 08/15/2024 | 200,097 | $4.18 M | 252.82% | 0.36% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 08/13/2024 | 174,393 | $3.64 M | 100.00% | 0.32% |
Nurix Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of NRIX shares?
During the previous two years, 200 institutional investors and hedge funds held shares of Nurix Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock Inc.: 6.82 M
Redmile Group, LLC: 4.42 M
Deep Track Capital, LP: 3.99 M
BAKER BROS. ADVISORS LP: 3.88 M
VANGUARD GROUP INC: 3.63 M
WELLINGTON MANAGEMENT GROUP LLP: 3.2 M
-
What percentage of Nurix Therapeutics, Inc. stock is owned by institutional investors?
118.38% of Nurix Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at NRIX ?
Institutional investors have bought a total of 74.00 M shares in the last 24 months. This purchase volume represents approximately $1.86 B in transactions.